FMC-NA Names Joe Turk New President for Renal Therapies Group

Joseph (Joe) Turk succeeds Mark Constanzo, who recently retired, as the new President for the Fresenius Medical Care North America Renal Therapies Group, and will now oversee the renal products and pharmaceutical operations.

Read the full article » | Posted 08-12-2021

Related Articles